Clinical and Experimental Vaccine Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.4 | Q4 | 9.8% | 0.404 | Q3 | 53.6% |
| 2024 | 1.3 | Q4 | 14.1% | 0.358 | Q3 | 51.3% |
| 2023 | 2.1 | Q4 | 21.4% | 0.359 | Q3 | 54.3% |
| 2022 | 2.7 | 26.0% | 0.456 | Q3 | 63.5% | |
| 2021 | — | 14.6% | 0.550 | Q2 | 70.1% | |
| 2020 | — | — | 0.958 | Q1 | 84.4% | |
| 2019 | — | — | 1.243 | Q1 | 89.8% | |
| 2018 | — | — | 1.022 | Q1 | 84.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2287-3651
ISSN
2287-366X
country
KRcoverage
2017-2026